Turning Point Therapeutics TPTX

$ 75.16 -0.13%

Quarterly report 2022-Q2
added 08-08-2022

Turning Point Therapeutics EV/EBITDA Ratio 2011-2024 | TPTX

Annual EV/EBITDA Ratio Turning Point Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-7.97	-29.7	-18.5	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-7.97	-29.7	-18.7